727 related articles for article (PubMed ID: 32522631)
21. Complex lipid trafficking in Niemann-Pick disease type C.
Vanier MT
J Inherit Metab Dis; 2015 Jan; 38(1):187-99. PubMed ID: 25425283
[TBL] [Abstract][Full Text] [Related]
22. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
Platt FM
Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1.
Wheeler S; Bhardwaj M; Kenyon V; Ferraz MJ; Aerts JMFG; Sillence DJ
FEBS Lett; 2024 Feb; 598(4):477-484. PubMed ID: 38302739
[TBL] [Abstract][Full Text] [Related]
25. TDP-43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann-Pick C disease.
Liu EA; Mori E; Hamasaki F; Lieberman AP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1019-1032. PubMed ID: 34048071
[TBL] [Abstract][Full Text] [Related]
26. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.
Chen J; Soni RK; Xu Y; Simoes S; Liang FX; DeFreitas L; Hwang R; Montesinos J; Lee JH; Area-Gomez E; Nandakumar R; Vardarajan B; Marquer C
EBioMedicine; 2023 Jun; 92():104628. PubMed ID: 37245481
[TBL] [Abstract][Full Text] [Related]
27. Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease.
Schultz ML; Krus KL; Lieberman AP
Brain Res; 2016 Oct; 1649(Pt B):181-188. PubMed ID: 27026653
[TBL] [Abstract][Full Text] [Related]
28. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.
Lloyd-Evans E; Morgan AJ; He X; Smith DA; Elliot-Smith E; Sillence DJ; Churchill GC; Schuchman EH; Galione A; Platt FM
Nat Med; 2008 Nov; 14(11):1247-55. PubMed ID: 18953351
[TBL] [Abstract][Full Text] [Related]
29. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
Lloyd-Evans E; Platt FM
Traffic; 2010 Apr; 11(4):419-28. PubMed ID: 20059748
[TBL] [Abstract][Full Text] [Related]
30. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
31. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
[TBL] [Abstract][Full Text] [Related]
32. Loss of Niemann-Pick C1 or C2 protein results in similar biochemical changes suggesting that these proteins function in a common lysosomal pathway.
Dixit SS; Jadot M; Sohar I; Sleat DE; Stock AM; Lobel P
PLoS One; 2011; 6(8):e23677. PubMed ID: 21887293
[TBL] [Abstract][Full Text] [Related]
33. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization.
Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM
Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112
[TBL] [Abstract][Full Text] [Related]
34. Activation of mammalian terget of rapamycin kinase and glycogen synthase kinase-3β accompanies abnormal accumulation of cholesterol in fibroblasts from Niemann-Pick type C patients.
Wos M; Komiażyk M; Pikula S; Tylki-Szymanska A; Bandorowicz-Pikula J
J Cell Biochem; 2019 Apr; 120(4):6580-6588. PubMed ID: 30390318
[TBL] [Abstract][Full Text] [Related]
35. NPC1-mTORC1 Signaling Couples Cholesterol Sensing to Organelle Homeostasis and Is a Targetable Pathway in Niemann-Pick Type C.
Davis OB; Shin HR; Lim CY; Wu EY; Kukurugya M; Maher CF; Perera RM; Ordonez MP; Zoncu R
Dev Cell; 2021 Feb; 56(3):260-276.e7. PubMed ID: 33308480
[TBL] [Abstract][Full Text] [Related]
36. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
[TBL] [Abstract][Full Text] [Related]
37. [Annexins in Niemann-Pick type C disease].
Buszewska ME; Strzelecka-Kiliszek A; Tylki-Szymańska A; Bandorowicz-Pikuła J
Postepy Biochem; 2007; 53(2):169-73. PubMed ID: 17969878
[TBL] [Abstract][Full Text] [Related]
38. Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy.
Mbua NE; Flanagan-Steet H; Johnson S; Wolfert MA; Boons GJ; Steet R
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10207-12. PubMed ID: 23733943
[TBL] [Abstract][Full Text] [Related]
39. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism.
Sitarska D; Ługowska A
Metab Brain Dis; 2019 Oct; 34(5):1253-1260. PubMed ID: 31197681
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal vitamin E accumulation in Niemann-Pick type C disease.
Yévenes LF; Klein A; Castro JF; Marín T; Leal N; Leighton F; Alvarez AR; Zanlungo S
Biochim Biophys Acta; 2012 Feb; 1822(2):150-60. PubMed ID: 22120593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
